KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,866,556 | +1.2% | 16,091 | +2.4% | 0.36% | +5.3% |
Q2 2023 | $1,844,824 | -6.8% | 15,714 | -36.5% | 0.34% | -12.1% |
Q1 2023 | $1,979,644 | -24.8% | 24,727 | -25.6% | 0.39% | -28.6% |
Q4 2022 | $2,633,669 | +13.0% | 33,245 | -0.6% | 0.54% | +7.5% |
Q3 2022 | $2,331,000 | +15.9% | 33,439 | +9.2% | 0.51% | +3.3% |
Q2 2022 | $2,011,000 | -10.8% | 30,630 | -9.6% | 0.49% | +16.9% |
Q1 2022 | $2,254,000 | -7.6% | 33,878 | -2.8% | 0.42% | +5.0% |
Q4 2021 | $2,439,000 | -18.8% | 34,867 | -49.8% | 0.40% | -57.1% |
Q1 2020 | $3,002,000 | -17.2% | 69,430 | +6.1% | 0.93% | +16.9% |
Q4 2019 | $3,625,000 | +18.7% | 65,463 | -25.5% | 0.80% | -1.2% |
Q3 2019 | $3,053,000 | -6.9% | 87,914 | +7.9% | 0.81% | +0.6% |
Q2 2019 | $3,280,000 | +336.8% | 81,447 | +256.9% | 0.80% | +335.9% |
Q1 2019 | $751,000 | +9.5% | 22,821 | -30.9% | 0.18% | -1.1% |
Q4 2018 | $686,000 | – | 33,025 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |